United States · FDA National Drug Code directory
Panzyga
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0069-1312_fb008bad-3696-e7b9-d3f8-3718e16e19d8
- Product NDC
- 0069-1312
- Form
- SOLUTION
- Composition / generic term
- immune globulin intravenous (human)
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Marketing category
- BLA
- Marketing start / end (source format)
- 20190809
- Source listing expiry
- 20271231
Source-listed ingredients
- HUMAN IMMUNOGLOBULIN G — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, GLASS in 1 CARTON (0069-1312-02) / 100 mL in 1 BOTTLE, GLASS (0069-1312-01) · 0069-1312-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →